Darren Ji
MD, PhD, MBA
Chief Executive Officer

Formerly, Bioscience Business Development Executive , Procter & Gamble Company; Responsible for multiple large deals in life science between P&G and East Asian countries; Seasoned leader in pharmaceutical R&D project management.

Jeff Duan
MD
General Manager

Formerly, Head of Pharmacology, Hutchison Medipharma (Shanghai); US board-certified MD; Extensive drug R & D experience in US and China biotech industry. Board member of Shanghai Experimental Animal Committee; Successful Submission of US and China INDs.

Mei-Shu Shih
DVM, PhD
Chief Scientific Officer

Formerly, Research Director of SkeleTech/ MDS and a research veterinary pathologist familiar with GLP operations; Over 25 years in research and specialized contract research services; Highly published and recognized in global bone professional communities.

Tom Tillotson

VP of Corporate Planning

A successful repeater entrepreneur with deep experience in operation and corporate planning. Successful history of managing international businesses, particularly across the US and Asia.

Li Li
CPA, MBA
VP of Finance

An expert on financial management, strategic and economic analysis and modeling. and business process improvement with 15 years of financial and leadership experience in U.S. Fortune 500 companies.

Cheng He Jin
MD, PhD
Executive Director Business Development

Formerly, an executive at Imagene Co Ltd; With a track record of success in multimillion dollar international collaboration deal and more than15 years experience in bioscience and business development.

Kevin (Hong) Zhang MD
MD
Senior Director, Pharmacology

Formerly held several Director and Associate Director-level positions in the areas of Drug Discovery, Pharmacology, GeneTrove (drug targets), and Pre-clinical Development for Isis. An innovator in the field of drug technologies, with more than 50 patents issued or filed.